Pharmaceutical News RSS Feed - Pharmaceutical News

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. [More]
High levels of dietary zinc increases susceptibility to Clostridium difficile infections

High levels of dietary zinc increases susceptibility to Clostridium difficile infections

Too much dietary zinc increases susceptibility to infection by Clostridium difficile - "C. diff" - the most common cause of hospital-acquired infections. [More]
MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure. [More]
Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease. [More]
The Lab offers new live resin extract pods designed for PAX Era vaporizer

The Lab offers new live resin extract pods designed for PAX Era vaporizer

The Lab, the concentrates production division of The Clinic and one of the leading cannabis extraction companies in Colorado, announced today its first ever live resin extract pods made exclusively for the new Era vaporizer by PAX Labs. [More]
Veracyte announces new data suggesting ability of Afirma GEC in thyroid cancer diagnosis

Veracyte announces new data suggesting ability of Afirma GEC in thyroid cancer diagnosis

Veracyte, Inc.today announced new data suggesting the potential to enhance the performance of the Afirma Gene Expression Classifier in thyroid cancer diagnosis by combining the test's proven RNA expression-based capabilities with gene variant and fusion information – all on a single, robust RNA sequencing platform. [More]
Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes. [More]
National Multiple Sclerosis Society calls for change to make MS drugs accessible

National Multiple Sclerosis Society calls for change to make MS drugs accessible

When Abigail Bostwick, 36, was diagnosed with multiple sclerosis in 2013, she never thought it would hit her as hard as it has -- not physically -- but financially. [More]
Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine

Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine

Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. [More]
Antibody drug offers new therapeutic approach for treating AML

Antibody drug offers new therapeutic approach for treating AML

An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia. [More]
Multifunctional nanocapsules could enhance drug delivery to specific disease sites

Multifunctional nanocapsules could enhance drug delivery to specific disease sites

A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors’ ability to target drugs to specific sites of disease. [More]
World leaders at UN meeting commit to develop action plans on antimicrobial resistance

World leaders at UN meeting commit to develop action plans on antimicrobial resistance

World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines. [More]
FDA approves new biosimilar for multiple inflammatory diseases

FDA approves new biosimilar for multiple inflammatory diseases

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. [More]
CRNAs use holistic approach to effectively manage pain with less opioid dependency

CRNAs use holistic approach to effectively manage pain with less opioid dependency

The holistic approach to patient care and pain management used by Certified Registered Nurse Anesthetists can help prevent opioid dependency, substance use disorder, drug overdoses and death, according to the American Association of Nurse Anesthetists. [More]
Magnetic bacteria can be promising vehicle for efficiently delivering tumor-fighting drugs

Magnetic bacteria can be promising vehicle for efficiently delivering tumor-fighting drugs

Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology. [More]
Virginia Tech researchers identify novel compound that blocks growth of deadly fungus

Virginia Tech researchers identify novel compound that blocks growth of deadly fungus

Researchers with the Virginia Tech Center for Drug Discovery have identified a compound that blocks the growth of a fungus that causes deadly lung infections and allergic reactions in people with compromised immune systems. [More]
JAK inhibitors may be first effective treatment for people with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

Seventy-five percent of patients with moderate to severe alopecia areata—an autoimmune disease that causes patchy, and less frequently, total hair loss—had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center. By the end of their treatment, average hair regrowth was 92 percent. [More]
Study data does not support benefits of testosterone supplementation in men with ‘low T’

Study data does not support benefits of testosterone supplementation in men with ‘low T’

The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with "low T" is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials published Sept. 21 in PLOS One. [More]
Progesterone treatment protects female mice against consequences of influenza infection

Progesterone treatment protects female mice against consequences of influenza infection

Over 100 million women are on hormonal contraceptives. All of them contain some form of progesterone, either alone or in combination with estrogen. [More]
Study shows maritime pine bark extract may be effective in limiting muscle loss due to aging

Study shows maritime pine bark extract may be effective in limiting muscle loss due to aging

A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65. [More]
Advertisement
Advertisement